Status:
RECRUITING
COVID-19 in PID Survey
Lead Sponsor:
Imagine Institute
Conditions:
Primary Immune Deficiency
COVID
Eligibility:
All Genders
Brief Summary
With the emergence of SARS-CoV-2 and the COVID-19 pandemic, there is an urgent need to understand the impact of infection on immunodeficient individuals. Whilst co-morbidities (such as diabetes, cance...
Eligibility Criteria
Inclusion
- Diagnosed with a Primary Immune Deficiency
- COVID-19 (proven or probable)
Exclusion
- Secondary Immune Deficiency
- Other Coronovirus infection
Key Trial Info
Start Date :
March 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 18 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04459689
Start Date
March 15 2020
End Date
February 18 2027
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imagine Institute
Paris, France, 75015